Device in drug program gets FDA approval

A device meant to help relieve the symptoms of withdrawal from opioid addiction has gotten clearance from the U.S. Food and Drug Administration.

The BRIDGE device is being used by a Greenwood city court program geared toward people addicted to opioids. The goal is to help relieve the symptoms of withdrawal, helping people in the program move ahead with treatment and recovery.

With the approval from the FDA, the BRIDGE device has now gotten clearance to be used as an approved method to relieve the symptoms of withdrawal. That means the device can be covered by insurance as soon as states and insurance companies approve it, according to a news release from Innovative Health Solutions, the company that makes the device.

The device is implanted behind the patient’s ear by a doctor and can relieve withdrawal symptoms in an hour, the release said.

“The technology gives those suffering from opioid addiction an easier transition to all forms medically assisted treatment,” said Brian Carrico, president of Innovative Health Solutions.

“The device helps take away the fear of withdrawal and leads to a much higher success rate.”

Author photo
Annie Goeller is managing editor of the Daily Journal. She can be reached at agoeller@dailyjournal.net or 317-736-2718.